Impact of agitation in long-term care residents with dementia in the United States.


Journal

International journal of geriatric psychiatry
ISSN: 1099-1166
Titre abrégé: Int J Geriatr Psychiatry
Pays: England
ID NLM: 8710629

Informations de publication

Date de publication:
12 2021
Historique:
received: 12 03 2021
accepted: 15 07 2021
pubmed: 22 7 2021
medline: 9 11 2021
entrez: 21 7 2021
Statut: ppublish

Résumé

To describe characteristics and compare clinical outcomes including falls, fractures, infections, and neuropsychiatric symptoms (NPS) among long-term care residents with dementia with and without agitation. A cross-sectional secondary analysis of administrative healthcare data was conducted whereby residents with dementia residing in a long-term care facility for ≥12 months were identified from the AnalytiCare LLC database (10/2010-06/2014) and were classified into mutually exclusive cohorts (Agitation Cohort or No-Agitation Cohort) based on available agitation-related symptoms. Entropy balancing was used to balance demographic and clinical characteristics between the two cohorts. The impact of agitation on clinical outcomes was compared between balanced cohorts using weighted logistic regression models. The study included 6,265 long-term care residents with dementia among whom, 3,313 were included in the Agitation Cohort and 2,952 in the No-Agitation Cohort. Prior to balancing, residents in the Agitation Cohort had greater dementia-related cognitive impairment and clinical manifestations compared to the No-Agitation Cohort. After balancing, residents with and without agitation, respectively, received a median of five and four distinct types of medications (including antipsychotics). Further, compared to residents without agitation, those with agitation were significantly more likely to have a recorded fall (OR = 1.58), fracture (OR = 1.29), infection (OR = 1.18), and other NPS (OR = 2.11). Agitation in long-term care residents with dementia was associated with numerically higher medication use and an increased likelihood of experiencing falls, fractures, infections, and additional NPS compared to residents without agitation, highlighting the unmet need for effective management of agitation symptoms in this population.

Identifiants

pubmed: 34286877
doi: 10.1002/gps.5604
pmc: PMC9291552
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1959-1969

Informations de copyright

© 2021 Otsuka Pharmaceutical Development and Commercialization Inc. International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd.

Références

Prim Care Companion J Clin Psychiatry. 2001 Jun;3(3):93-109
pubmed: 15014607
Health Aff (Millwood). 2000 May-Jun;19(3):40-56
pubmed: 10812780
Int J Geriatr Psychiatry. 2021 Dec;36(12):1959-1969
pubmed: 34286877
Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):231-8
pubmed: 12611753
J Am Geriatr Soc. 2002 Oct;50(10):1629-37
pubmed: 12366615
Clin Interv Aging. 2016 Feb 22;11:175-84
pubmed: 26955265
Curr Psychiatry Rep. 2012 Aug;14(4):298-309
pubmed: 22644311
Int J Geriatr Psychiatry. 2006 Mar;21(3):281-7
pubmed: 16477582
J Geriatr Psychiatry Neurol. 2007 Mar;20(1):41-9
pubmed: 17341770
J Gerontol. 1989 May;44(3):M77-84
pubmed: 2715584
Int Psychogeriatr. 2002 Dec;14(4):379-88
pubmed: 12670059
Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):285-90
pubmed: 19812472
J Trauma. 2011 Sep;71(3):748-53
pubmed: 21045738
Curr Opin Psychiatry. 2013 May;26(3):252-9
pubmed: 23528917
Cost Eff Resour Alloc. 2019 Apr 27;17:9
pubmed: 31061640
Int Psychogeriatr. 2015 Jan;27(1):7-17
pubmed: 25311499
Health Aff (Millwood). 2014 Apr;33(4):650-7
pubmed: 24711327
Geriatr Gerontol Int. 2009 Mar;9(1):41-6
pubmed: 19260978
BJPsych Open. 2017 Jul 27;3(4):171-178
pubmed: 28794896
J Gerontol Nurs. 2008 Dec;34(12):8-15; quiz 16-7
pubmed: 19112999
J Am Geriatr Soc. 2018 Apr;66(4):693-698
pubmed: 29512120
JAMA Intern Med. 2014 Oct;174(10):1660-7
pubmed: 25133863
J Am Geriatr Soc. 2013 Jan;61(1):62-6
pubmed: 23311553
Dialogues Clin Neurosci. 2003 Mar;5(1):49-59
pubmed: 22034255
Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1797-804
pubmed: 22274858
J Am Geriatr Soc. 2020 Mar;68(3):595-602
pubmed: 31912482
Am J Psychiatry. 2000 May;157(5):708-14
pubmed: 10784462
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
J Res Med Sci. 2013 Jul;18(7):601-10
pubmed: 24516494
Am J Geriatr Psychiatry. 2006 Mar;14(3):191-210
pubmed: 16505124
J Am Med Dir Assoc. 2019 Aug;20(8):956-962.e8
pubmed: 31129021
J Am Med Dir Assoc. 2014 Jul;15(7):504-508
pubmed: 24679926
Int J Geriatr Psychiatry. 2001 Jan;16(1):39-44
pubmed: 11180484
Dement Geriatr Cogn Dis Extra. 2017 Jun 19;7(2):195-203
pubmed: 28690633
J Appl Gerontol. 1990 Mar;9(1):106-17
pubmed: 10103778
Front Aging Neurosci. 2016 Apr 21;8:72
pubmed: 27148044
Am J Geriatr Psychiatry. 1994 Spring;2(2):157-164
pubmed: 28530995
PLoS One. 2018 Jul 31;13(7):e0198004
pubmed: 30063697
Nurs Econ. 2016 Jan-Feb;34(1):16-24
pubmed: 27055307
Curr Treat Options Neurol. 2019 Jun 24;21(7):30
pubmed: 31231784
Curr Alzheimer Res. 2016;13(10):1124-33
pubmed: 27160166
Int J Geriatr Psychiatry. 2003 Jun;18(6):527-32
pubmed: 12789674
Age Ageing. 2004 Jan;33(1):58-65
pubmed: 14695865
Aging Ment Health. 2006 Jul;10(4):362-7
pubmed: 16798628
J Clin Epidemiol. 1999 Apr;52(4):273-80
pubmed: 10235167
J Neuropsychiatry Clin Neurosci. 2002 Winter;14(1):11-8
pubmed: 11884649
Int Psychogeriatr. 2010 May;22(3):346-72
pubmed: 20096151
BMC Neurol. 2019 Feb 28;19(1):33
pubmed: 30819136
Osteoporos Int. 2006;17(6):807-16
pubmed: 16520889

Auteurs

Howard Fillit (H)

Geriatric Medicine, Palliative Care and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Myrlene S Aigbogun (MS)

Health Economics and Outcomes Research, Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ, USA.

Patrick Gagnon-Sanschagrin (P)

Analysis Group, Inc., Montreal, QC, Canada.

Martin Cloutier (M)

Analysis Group, Inc., Montreal, QC, Canada.

Mikhaïl Davidson (M)

Analysis Group, Inc., Montreal, QC, Canada.

Elizabeth Serra (E)

Analysis Group, Inc., Montreal, QC, Canada.

Annie Guérin (A)

Analysis Group, Inc., Montreal, QC, Canada.

Ross A Baker (RA)

Health Economics and Outcomes Research, Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ, USA.

Christy R Houle (CR)

Health Economics and Outcomes Research, Lundbeck Pharmaceuticals, Deerfield, IL, USA.

George Grossberg (G)

Geriatric Psychiatry, Saint Louis University School of Medicine, Saint Louis, MO, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH